drugset / Trial / NCT00369265

Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux

NCT00369265

Phase 4 Terminated 18 enrolled American Institute for Voice and Ear Research
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether Lansoprazole 30mg taken twice daily is effective in the treatment of laryngitis due to gastroesophageal reflux.

Timeline

Start
2006-08
Primary completion
2009-11
Completion
2009-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lansoprazole Other / unclassified 30 mg